Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors

Journal of Immunology

Volumn 156, Issue 3, 1996, Pages 1117-1125

  Liu, Bai ^a   Podack, Eckhard R ^a   Allison, James P ^b   Malek, Thomas R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; LEWIS CARCINOMA; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; THYMOMA; TUMOR IMMUNITY; TUMOR REJECTION;

ANIMALS; ANTIGENS, CD80; ANTIGENS, NEOPLASM; CARCINOMA, LEWIS LUNG; CYTOTOXICITY, IMMUNOLOGIC; GROWTH INHIBITORS; IMMUNOPHENOTYPING; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MAST-CELL SARCOMA; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0030070974     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Linsley, P S , and J A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
2. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
3. Boussiotis, V. A., D. L. Barber, T. Nakarai, G. J. Freeman, J. G Gribben, G M Bernstein, A. D D'Andrea, J Ritz, and L. M. Nadler. 1994 Prevention of T cell anergy by signaling through the γ-chain of the IL-2 receptor. Science 266:1039.
4. Boon, T. 1992. Toward a genetic analysis of tumor rejection antigens. Adv. Cancer Res. 58:177.
5. Boon, T., J. C. Cerottini, B. Van den Eynde, P. Van den Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol 12. 337.
6. Cox, A. L , J Skipper, Y Chen, R. A. Henderson, T. L. Darrow, J. Shabanowitz, V. H. Engelhard, D F. Hunt, and C. L. Slingluff, Jr. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264.716.
7. Van den Bruggen, P., C. Traversari, P Chomez, C. Lurquin, E De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytotoxic T lymphocytes on a human melanoma. Science 254: 1643.
8. Tepper, R. I., P K Pattengale, and P Leder. 1989. Murine interleukin-4 displays potent antitumor activity in vivo. Cell 57 503.
9. Fearon, E. R., D. M. Pardoll, D. Itaya, P. Golumbek, H. I. Levitsky, J. W. Simons, H. Karasuyama, B. Vogelstein, and P Frost. 1990. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397.
10. Gansbacher, B , K. Zier, B. Daniels, K. Cronin, R. Bannerji, and E Gilboa. 1990 Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp Med. 172.1217
11. Schwartz, R. H 1992 Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71 1065.
12. Chen, L , P S. Linsley, and K E Hellstrom 1993 Costimulation of T cells for tumor immunity. Immunol Today 14:483.
13. Chen, L., S Ashe, W A Brady, I Hellström, K. E. Hellström, J. A. Ledbetter, P. McGowan, and P. S. Lindsley. 1992 Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA4 Cell 71:1093
14. Baskar, S., S. Ostrand-Rosenberg, N Nabavi, L M. Nadler, G. J. Freeman, and L. H. Glimcher 1993 Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad Sci. USA 90 5687.
15. + T cells by B7-transfected melanoma cells. Science 259 368
16. Ley, V., P. Langlade-Demoyen, P Kourlisky, and E. L. Larsson-Sciard. 1991. Interleukin-2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 21.851.
17. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I Hellstrom, and K. E Hellstrom 1994 Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity J. Exp. Med. 179:523.
18. Townsend, S. E., F. W. Su, J M. Atherton, and J P Allison 1994. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res. 54:6477.
19. Greenberg, P. D 1991. Adoptive T cell therapy of tumors; mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49:281.
20. Melief, C. J M 1992 Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 58:143.
21. Rosenberg, S A., P. Spiess, and R. Lafreniere 1986 A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318.
22. Gajewski, T. F , J.-C. Renauld, A. Van Pel, and T. Boon. 1995. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine anti-tumor cytolytic T lymphocytes in vitro J. Immunol 154:5637.
23. Dunn, T. B., and M. Potter. 1957 A transplantable mast cell neoplasm in the mouse. J Natl. Cancer Inst. 18:587
24. Gorer, P. A., and D. B. Amos. 1959. Passive immunity in mice against C57BL leukosis E.L.4 by means of isoimmune serum. Cancer Res. 16.338.
25. Bertran, J. S , and P. Janik. 1980. Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell culture Cancer Lett 11:63.
26. Kiessling, R., E Klein, and H. Wigzell 1975 "Natural" killer cells in the mouse I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotypes. Eur. J. Immunol. 5:112.
27. Uyttenhove, C., J. Maryanski, and T Boon 1983. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than to immunosuppression J. Exp. Med. 157:1040.
28. Van den Eynde, B., B. Lethe, A. Van Pel, E. De Plaen, and T. Boon. 1991 The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med. 173:1373.
29. Karasuyama, H., and F. Merchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin-2, -3, -4, or -5 using modified cDNA expression vectors. Eur. J. Immunol. 18 97
30. Malek, T. R., J. A. Schmidt, and E. M. Shevach. 1985. The murine interleukin-2 receptor. III. Cellular requirements for the induction of interleukin-2 receptor expression on T cell subpopulations J. Immunol. 134 2405
31. Codias, E. K., and T R Malek. 1993. Subsets of activated CD4 T lymphocytes refractory for secretion of interleukin-2 are distinguished by expression of Ly-6A/E in BALB/c mice J Immunol. 151:5918
32. Ceredig, R., J W. Lowenthal, M Nabholz, and H. R. MacDonald 1985. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314:98.
33. Ledbetter, J. A , and L A Herzenberg. 1979 Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigen Immunol. Rev 47:63.
34. Bruce, J., F W. Symington, T. J Mckearn, and J. Sprent. 1981. A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol 127:2496.
35. Springer, T. A. 1980 Cell-surface differentiation in the mouse. In Monoclonal Antibodies. R. H. Kennett, T. J. McKearn, and K. B. Bechtol, eds. Plenum Publishing Corp, New York.
36. Bhattacharya, A., M E. Dorf, and T. A Springer 1981. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication J. Immunol. 127:2488
37. Lane, P , W. Gerhard, S. Hubele, A Lanzavecchia, and F. McConnoll 1993. Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human γ1. Immunology 80:56.
38. Malek, T. R , R. J. Robb, and E. M. Shevach 1983 Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin-2 receptor-ligand complex. Proc Natl. Acad. Sci. USA 80:5694.
39. Isakov, N., S. Katzav, M. Feldman, and S Segal 1983. Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties. J. Natl. Cancer Inst 71:139.
40. Linsley, P. S , W. Brady, M. Umes, L. S. Grosmaire, N. K. Damle, and J. A Ledbetter. 1991. CTLA4 is a second receptor for the B cell activation antigen B7 J Exp. Med. 174:561
41. Young, M. R. I., M. A. Wright, and M. E. Young 1991. Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immunosuppressive bone marrow cells. Cancer Immunol Immunother. 33:146.
42. Kawakami, Y., S. A. Rosenberg, and M. T. Lotze. 1988. Interleukin-4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J Exp. Med. 163:2183.
43. Lotze, M. T., M. C. Custer, Y. Kawakami, H. Stotter, J. T. Rubin, E. S. Bolton, L. Guedez, and M. G. Sanda. 1990. T cell growth factors and the expansion of lymphoid cells with antitumor activity in vitro and in vivo. In Cellular Immunity and the Immunotherapy of Cancer. M. T Lotze and O. J. Finn, eds Wiley-Liss, Inc., New York, p. 91.
44. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177.1791.
45. Springer, T A. 1990. Adhesion receptors of the immune system. Nature 346: 425.
46. van Seventer, G. A., W. Newman, Y. Shimizu, T. B. Nutrnan, Y. Tanaka, K. J Horgan, T. V. Gopal, E. Ennis, D. O'Sullivan, H. Grey, and S. Shaw. 1991. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or CD3 monoclonal antibody costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J. Exp. Med. 174:901.
47. + T lymphocytes. J Immunol. 148:1985.
48. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271.
49. Colombo, M. P , and G. Forni. 1994. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol. Today 15:48.
50. Stevens, E. J., L. Jacknin, P. F. Robbins, Y. Kawakami, M El Gamil S. A. Rosenberg, and J. R. Yannelli. 1995. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. J. Immunol. 154:672.
51. Celis, E., V. Tsai, R. Crimi, P. A. DeMars, R. W. Wentworth, H. M. Chesnut, A. Grey, A. Sette, and H M. Serra. 1994. Induction of antitumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91.2105.
52. Peace, D. J., J W. Smith, W. Chen, S. J. You, W. L. Cosand, J. Blake, and M. A. Cheever. 1994 Lysis of Ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated Ras peptide J. Exp. Med. 179.473.